Company
Amgen Inc
NASDAQ:AMGN
Amgen Inc is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology.
45 stories · page 1 of 3
Nasdaq ends four-day rally as Wall Street takes a breather
SpaceX wiped about $170 billion from its market value following its first results since listing
Salesforce stock rallies as it prepares to join Dow Jones
Salesforce, Amgen and Honeywell all advanced ahead of the Dow reshuffle later this month.
Imugene appoints global pharmaceutical executive to its board
Dr. Lesley Russell brings extensive pharmaceutical experience to the board including a number of cancer therapy collaborations with Teva Pharmaceuticals.
Provention Bio rises after saying Phase 3 study for diabetes drug candidate to begin in 2Q
The biopharmaceutical company says it has entered into an agreement with a clinical research organization to conduct a study of PRV-031
Investments and investor services
EARLY MOVERS: Entera Bio shares soar on collaboration deal with Amgen
CalAmp shares slump due to supply disruptions in moving supply chain out of China
AstraZeneca’s severe asthma treatment granted breakthrough therapy designation
A breakthrough therapy designation is designed to expedite the development and review of medicines that are intended to treat a serious and have shown promise in early-stage clinical trials
Amgen beats 2Q estimates and raises full-year forecast, vows to not hike drug prices again this year
The drugmaker said it would not raise prices this year; Pfizer and Novartis have made similar promises
Amgen Inc. beats the Street boosted by new drug sales
The biotech firm beat analyst expectations on profit and revenue
Amgen shares slip as biotech behemoth misses fourth quarter expectations
The latest results were impacted by a US$6.1bn charge related to the new US tax laws
Buffalo Wild Wings, Amgen Inc and Las Vegas Sands Corp - AFTER HOURS
A look at the risers and fallers after-hours in New York trade
Pfizer, Amgen , Clovis Oncology and more - PRE-MARKET
A look at what stocks are moving the needle, up and down, before the bell in New York
Amgen shares fall as it reveals new cardiovascular risks for its Evenity osteoporosis drug
It said the data showed Evenity having an imbalance in serious cardiovascular adverse events as compared with the current standard of care in osteoporosis, alendronate